成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>133825-81-7

133825-81-7

中文名稱(chēng) NEVANIMIBE HYDROCHLORIDE
英文名稱(chēng) PD 132301-2
CAS 133825-81-7
更新日期 2023/03/20 15:41:21
分子式 C27H40ClN3O
分子量 458.09
MOL 文件 133825-81-7.mol
133825-81-7 結(jié)構(gòu)式 133825-81-7 結(jié)構(gòu)式

基本信息

中文別名
化合物NEVANIMIBE HYDROCHLORIDE
英文別名
ATR-101 HCl
PD 132301-2
Nevanimibe)
ATR-101 (PD-132301
ATR101 hydrochloride
PD-132301 hydrochloride
Nevanimibe hydrochloride

物理化學(xué)性質(zhì)

儲(chǔ)存條件4°C, away from moisture
溶解度DMSO : 41.67 mg/mL (90.97 mM; Need ultrasonic)| (insoluble)
形態(tài)Solid
顏色White to off-white
水溶解性Water : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
NEVANIMIBE HYDROCHLORIDE價(jià)格(試劑級(jí))
報(bào)價(jià)日期產(chǎn)品編號(hào)產(chǎn)品名稱(chēng)CAS號(hào)包裝價(jià)格
2024/11/08HY-100399ANEVANIMIBE HYDROCHLORIDE
Nevanimibe hydrochloride
133825-81-75mg2900元
2024/11/08HY-100399ANEVANIMIBE HYDROCHLORIDE
Nevanimibe hydrochloride
133825-81-710mM * 1mLin DMSO3190元
2024/11/08HY-100399ANEVANIMIBE HYDROCHLORIDE
Nevanimibe hydrochloride
133825-81-710mg4600元

常見(jiàn)問(wèn)題列表

生物活性
Nevanimibe hydrochloride (PD-132301 hydrochloride) 是一種口服有效的,選擇性?;o酶 A:膽固醇 O-?;D(zhuǎn)移酶 1 (ACAT1) 抑制劑,EC50 為 9 nM。Nevanimibe hydrochloride 抑制 ACAT2,EC50 為 368 nM。Nevanimibe hydrochloride 誘導(dǎo)細(xì)胞凋亡 (apoptosis),并具有抗腎上腺皮質(zhì)癌的潛力。
靶點(diǎn)

ACAT1

9 nM (EC 50 )

ACAT2

368 nM (EC 50 )

體外研究

Coincubation of Nevanimibe hydrochloride (PD-132301 hydrochloride; ATR101 hydrochloride; 3 nM-30 μM) and Cholesterol markedly increases toxicity in a dose-dependent manner, where 3 nM Nevanimibe in the presence of 60 μg/mL Cholesterol reduces survival by 60% after 24 hours. All doses of Nevanimibe (3 nM-30 μM) induces cytoxicity in the presence of Cholesterol, whereas treatment with Cholesterol in the absence of Nevanimibe has no effect on cell viability.

Cell Cytotoxicity Assay

Cell Line: The H295R and HAC clone 15 (HAC15) human ACC cell lines
Concentration: 3 nM-30 μM
Incubation Time: 24 hours
Result: 3 nM-3 μM exhibited no toxicity, whereas 30 μM treatment reduced survival by approximately 40% within 24 hours.
"133825-81-7" 相關(guān)產(chǎn)品信息
7440-41-7